A method is described for estimating plasma and urinary hemoglobin concentrations as low as 3 mg/L The assay measures at 528 nm the rate of peroxidation of chlorpromazine by hemoglobin and is not affected by ascorbate and bilirubinconcentrations up to 500 mol/L. Results by this method (mean ± SD: 54.4 ± 41.6 mg/L; n = 19) correlated well with those by a scanning spectrophotometric method (52.5 ± 41.6 mg/L; r = 0.96) and a Coulter Instrument method (I' = 0.99; Coulter method: 125 ± 15 g/L rate method: 122 ± 15 g/L; n = 10, r = 0.99). The correlation for assays of 20 plasma samples by our method and a tetramethylbenzidine method was also good (r = 0.95) though the latter gave lower results (31.1 ± 31.6 mgIL) than the chlorpromazine method (50.9 ± 41.1 mg/L). The chlorpromazine rate method gave an intra-and interday CV of 7.9% and 9.7%, respectively, at a hemoglobin concentration of 31 mg/L. 
.
In one potentially useful method, a noncarcinogenic peroxidase substrate, chiorpromazine, was used with an eiidpoint spectrophotometric measurement of Nb (8, 9) . Using this method (8), we found that higher concentrations of Hb reached the endpoint earlier and the maximal absorbance at the endpoint lasted only 30 to 60 s. To overcome this problem, we tried a rate kinetic method to estimate Hb. The results of this study are presented here.
Materials and Methods

Materials
Acetic acid/phosphoric acid solution.
To 28 mL of glacial acetic acid add 4 mL of concentrated H3P04; the 
Procedures
Blood collection.
We tested the following blood-collection tubes as to their suitability for estimation of plasma Nb. To do this, we assessed intra-and intertube van no. B4126), and bilirubin (from two icteric plasmas from patients with obstructive jaundice) were tested as possible interferents in the assay. We dissolved ascorbic acid and bilirubin in water and NaOH (0.1 mol/L), respectively, to give 50 mmol/L concentrations.
A 100-fold dilution of these in plasma gave the highest concen- no. X555) was tested at 40 mgfL in CA solution for interference with the plasma Nb method.
Other procedures.
We used a Beckman DU 7500 diode-array spectrophotometer to measure rates. All gases used were of highest purity and purchased from CIG Industries (Adelaide, Australia).
Other reagents used were AR grade.
In the recovery experiments, the Coulter 4C-plus Reference Control was diluted to an Nb content of 1 Figure IA presence of increasing amounts of chlorpromazine in a 1.9 mol/L H3P04 solution in glacial acetic acid is shown in Figure lB . Maximal activity when the chlorpromazine reagent was -10 gIL (assay concentration 1.6 gIL), so we used this concentration for our assay. The rate obtained was linear over the 3- Assay of 10 separate plasma specimens supplemented with standards to give added Hb concentrations of 16 and 80 mg/L gave recoveries ranging from 95% to 110%. In 10 fresh urine specimens from healthy persons Hb was not detected. Adding Nb to these urines at 16 and 80 mg/L gave recoveries ranging from 95% to 109%. These results taken together indicate the lack of effect of possible inhibitors on the rate method and good correlation with reliable assay methods.
A plasma sample assayed 30 times in one day gave a mean Nb of 31 mg/L, with a CV of 7.9%. This same sample stored frozen at -20 #{176}C and assayed 12 times over the next month gave a mean of 34 mg Nb/L with aCV of 9.7%. Intra-and interblood collection-tube comparisons for the plasma Hb rate method were performed with blood from a healthy donor, as described in Materials and Methods.
The results showed considerable intra-and intertube variation in the plasma Nb concentrations (Figure 3) . This same blood collected into 1-mL EDTAcontaining tubes gave plasma Nb concentrations that were 2.5-to 20-fold higher than the 1-mL heparincontaining tubes (Nb >300 mg/L; data not shown). Obviously, therefore, the choice of specimen tube used for blood collection is very critical for analysis of plasma Nb: We found that the heparin Vacuette tube (Greiner) was the most suitable. In this tube the heparin is mist-sprayed into the tube; in contrast, it is pipetted into the larger l0-mL tube, which may explain in part the variations in the results obtained with different collection tubes. These results are consistent with the recommended method for blood collection in plasma Hb assays, which suggests that tubes be mist-8prayed with heparin (1000 IU/mL) before blood collection (1). In conclusion, we present a rate kinetic method for the analysis of plasma Nb that is an adaptation of previous assays based on endpoint measurement (8, 9 
